Trajectories of COVID-19 information in the Annals of the Rheumatic Diseases: the first months of the pandemic.

Lauper, Kim; Bijlsma, Johannes W J; Burmester, Gerd R

Lauper, Kim; Bijlsma, Johannes W J; Burmester, Gerd R.

Lauper K; Division of Rheumatology, Geneva University Hospitals and Faculty of Medicine, University of Geneva, Geneva, Switzerland Kim.Lauper@hcuge.ch.
Bijlsma JWJ; Centre for Epidemiology Versus Arthritis, Centre for Musculoskeletal Research, University of Manchester, Manchester, UK.
Burmester GR; Department of Rheumatology and Clinical Immunology, UMC Utrecht, Utrecht, Netherlands.

Ann Rheum Dis ; 80(1): 26-30, 2021 01.

Article in English | MEDLINE | ID: covidwho-873482

Subject(s)

Bibliometrics; COVID-19; Rheumatic Diseases; Rheumatology; Humans; SARS-CoV-2

Keywords

antirheumatic agents; biological therapy; communicable diseases; hydroxychloroquine; imported

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Rheumatology / Bibliometrics / Rheumatic Diseases / COVID-19 Limits: Humans Language: English Journal: Ann Rheum Dis Year: 2021 Document Type: Article Affiliation country: Annrheumdis-2020-219217

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google